Ingredients

GettyImages: Devonyu

Lundbeck to buy Prexton in potential $1bn+ deal

By Staff Reporter

The Danish drugmaker says it will take responsibility for commercial manufacturing after acquiring Parkinson’s disease candidate foliglurax in a deal worth up to €905m ($1.1bn).

Gettyimages/Pattadis Walarput

news in brief

Ipca buys API firm Pisgah Labs

By Gareth Macdonald

Ipca Pharmaceutical Inc. has acquired North Carolina drug ingredient firm Pisgah Labs for $9.65m.